207
Participants
Start Date
June 15, 2022
Primary Completion Date
February 15, 2023
Study Completion Date
February 15, 2023
24-Valent Pneumococcal Conjugate Vaccine
0.5 ml dose of VAX-24 will be administered into the deltoid muscle at Day 1
Pneumococcal 20-valent Conjugate Vaccine
0.5 ml dose of Prevnar 20 will be administered into the deltoid muscle at Day 1
Charlottesville Medical Research, Charlottesville
Accellacare of Rocky Mount, Rocky Mount
Coastal Carolina Research, North Charleston
Accellacare of Charleston, Mt. Pleasant
Pivotal Research Solutions, Stonecrest
Meridian Clinical Research, Savannah
Accel Research Sites - DeLand Clinical Research Unit, DeLand
CenExel RCA, Hollywood
Precision Clinical Research, Sunrise
Accel Research Sites-Birmingham Clinical Research Unit, Birmingham
Meridian Clinical Research, Cincinnati
Healthcare Research Network II, LLC, Flossmoor
Healthcare Research Network, Hazelwood
AMR Newton, formerly Heartland Research Associates, Newton
AMR Wichita West, Wichita
Meridian Clinical Research, Omaha
AMR New Orleans, New Orleans
Clinical Trials of Texas, LLC, San Antonio
Velocity Clinical Research, Salt Lake City, West Jordan
CenExel JBR Clinical Research, Salt Lake City
Vaxcyte, Inc.
INDUSTRY